Goldman Sachs Initiates Coverage On Boston Scientific with Buy Rating, Announces Price Target of $90
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs has initiated coverage on Boston Scientific with a Buy rating and set a price target of $90.
May 30, 2024 | 11:55 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Goldman Sachs has initiated coverage on Boston Scientific with a Buy rating and set a price target of $90.
The initiation of coverage with a Buy rating and a high price target by a major financial institution like Goldman Sachs is likely to positively impact Boston Scientific's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100